USA FINANCIAL FORMULAS - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
USA FINANCIAL FORMULAS ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$46,833
+5.9%
1,2260.0%0.07%
+2.9%
Q2 2023$44,222
-10.7%
1,226
-5.4%
0.07%
-15.0%
Q1 2023$49,494
-71.1%
1,296
-67.7%
0.08%
-40.7%
Q4 2020$171,000
-37.4%
4,011
-61.3%
0.14%
-34.5%
Q3 2020$273,00010,3710.21%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders